Biosimilars reimbursement issues. Supply Chain Issues. Pharmacy Benefit Manager Reform.
2025 · 3rd Quarter (July 1 - Sep 30)
BRISTOL-MYERS SQUIBB COMPANY
Filed by TODD STRATEGY GROUP.
Open official filingSource-reported fields
Filing overview
- Type
- 3rd Quarter - Report
- Posted
- Oct 21, 2025
- Income
- $50,000.00
- Expenses
- Not reported
- Registrant
- TODD STRATEGY GROUP
- Filing UUID
- adef8d21-e791-428e-8005-6ff084144201
- Termination date
- Not reported
Literal source text
Lobbying issues and bill citations
Medicare/Medicaid payment reform. Implementation of Inflation Reduction Act of 2022. 340B Program.
Relationship and amount limits
Bill links use only the filing year’s mathematically derived Congress plus the literal measure type and number in the issue description. Unmatched citations remain plain text. Politically.com does not join on names, infer advocacy positions, combine amendments, or calculate totals across filings.